A detailed history of Principal Financial Group Inc transactions in Staar Surgical CO stock. As of the latest transaction made, Principal Financial Group Inc holds 277,584 shares of STAA stock, worth $7.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
277,584
Previous 300,973 7.77%
Holding current value
$7.4 Million
Previous $14.3 Million 28.03%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$29.97 - $47.42 $700,968 - $1.11 Million
-23,389 Reduced 7.77%
277,584 $10.3 Million
Q2 2024

Jul 29, 2024

SELL
$38.07 - $52.25 $64,566 - $88,616
-1,696 Reduced 0.56%
300,973 $14.3 Million
Q1 2024

Apr 29, 2024

BUY
$27.67 - $39.61 $599,387 - $858,031
21,662 Added 7.71%
302,669 $11.6 Million
Q4 2023

Feb 07, 2024

SELL
$30.6 - $43.78 $5.43 Million - $7.77 Million
-177,467 Reduced 38.71%
281,007 $8.77 Million
Q3 2023

Nov 02, 2023

BUY
$39.39 - $58.12 $31,551 - $46,554
801 Added 0.18%
458,474 $18.4 Million
Q2 2023

Aug 07, 2023

SELL
$50.45 - $72.82 $11.1 Million - $16 Million
-220,042 Reduced 32.47%
457,673 $24.1 Million
Q1 2023

May 09, 2023

SELL
$51.25 - $79.34 $403,798 - $625,119
-7,879 Reduced 1.15%
677,715 $43.3 Million
Q4 2022

Feb 09, 2023

SELL
$46.82 - $76.2 $352,320 - $573,405
-7,525 Reduced 1.09%
685,594 $33.3 Million
Q3 2022

Nov 09, 2022

BUY
$70.55 - $111.58 $10.2 Million - $16.2 Million
144,923 Added 26.44%
693,119 $48.9 Million
Q2 2022

Aug 10, 2022

BUY
$50.24 - $80.48 $7.15 Million - $11.5 Million
142,386 Added 35.09%
548,196 $38.9 Million
Q1 2022

May 09, 2022

BUY
$57.98 - $93.5 $3.72 Million - $5.99 Million
64,087 Added 18.75%
405,810 $32.4 Million
Q4 2021

Feb 09, 2022

SELL
$88.02 - $127.79 $22,533 - $32,714
-256 Reduced 0.07%
341,723 $31.2 Million
Q3 2021

Nov 09, 2021

BUY
$122.75 - $162.68 $6.51 Million - $8.63 Million
53,032 Added 18.35%
341,979 $44 Million
Q2 2021

Aug 10, 2021

SELL
$105.76 - $154.96 $222,096 - $325,416
-2,100 Reduced 0.72%
288,947 $44.1 Million
Q1 2021

May 10, 2021

BUY
$78.5 - $126.48 $12.7 Million - $20.5 Million
162,187 Added 125.86%
291,047 $30.7 Million
Q4 2020

Feb 08, 2021

BUY
$55.93 - $82.78 $387,706 - $573,830
6,932 Added 5.69%
128,860 $10.2 Million
Q3 2020

Nov 06, 2020

SELL
$45.65 - $61.81 $11.6 Million - $15.8 Million
-255,048 Reduced 67.66%
121,928 $6.9 Million
Q2 2020

Aug 05, 2020

BUY
$29.15 - $61.54 $4.45 Million - $9.4 Million
152,751 Added 68.12%
376,976 $23.2 Million
Q1 2020

May 12, 2020

SELL
$25.01 - $42.4 $3.13 Million - $5.31 Million
-125,302 Reduced 35.85%
224,225 $7.23 Million
Q4 2019

Feb 05, 2020

SELL
$24.55 - $38.13 $799,004 - $1.24 Million
-32,546 Reduced 8.52%
349,527 $12.3 Million
Q3 2019

Nov 13, 2019

BUY
$25.78 - $34.8 $114,978 - $155,208
4,460 Added 1.18%
382,073 $9.85 Million
Q2 2019

Aug 12, 2019

BUY
$23.08 - $37.01 $1.56 Million - $2.5 Million
67,655 Added 21.83%
377,613 $11.1 Million
Q1 2019

May 10, 2019

BUY
$27.81 - $40.78 $749,423 - $1.1 Million
26,948 Added 9.52%
309,958 $10.6 Million
Q4 2018

Feb 14, 2019

BUY
$28.91 - $50.0 $706,097 - $1.22 Million
24,424 Added 9.45%
283,010 $9.03 Million
Q3 2018

Nov 14, 2018

BUY
$30.85 - $50.65 $1.34 Million - $2.2 Million
43,505 Added 20.23%
258,586 $12.4 Million
Q2 2018

Aug 13, 2018

BUY
$13.95 - $32.65 $98,361 - $230,215
7,051 Added 3.39%
215,081 $0
Q1 2018

May 14, 2018

SELL
$14.35 - $16.5 $96,231 - $110,649
-6,706 Reduced 3.12%
208,030 $3.08 Million
Q4 2017

Feb 13, 2018

SELL
$12.45 - $17.4 $1.09 Million - $1.52 Million
-87,288 Reduced 28.9%
214,736 $3.33 Million
Q3 2017

Nov 02, 2017

BUY
$10.25 - $12.8 $3.1 Million - $3.87 Million
302,024
302,024 $3.76 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.28B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.